Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1

Cell Growth and Differentiation

Volumn 12, Issue 7, 2001, Pages 363-369

  Jiang, B H ^a   Jiang, G ^a   Zheng, J Z ^a   Lu, Z ^a   Hunter, T ^a   Vogt, P K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR; GENE PRODUCT; HYPOXIA INDUCIBLE FACTOR 1; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; BLOTTING, NORTHERN; CELL FRACTIONATION; CHROMONES; CULTURE MEDIA, SERUM-FREE; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; INSULIN; LYMPHOKINES; MORPHOLINES; NUCLEAR PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034925041     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase
2. The catalytic subunit of phosphoinositide 3-kinase: Requirements for oncogenicity
3. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
4. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
5. AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoi-nositide-dependent phosphorylation
6. Cellular survival: A play in three Akts
7. Cellular signaling: Pivoting around PDK-1
8. The PI3K-PDK1 connection: More than just a road to PKB
9. PIK3CA: Determining its role in cellular proliferation and ovarian cancer
10. PIK3CA as an oncogene in cervical cancer
11. PIK3CA is implicated as an oncogene in ovarian cancer
12. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
13. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma
14. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies
15. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer
16. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
17. The multiple roles of PTEN in tumor suppression
18. Advances in the molecular genetics of endometrial cancer
19. Chromosome 10 alterations in prostate adenocarcinoma
20. Molecular pathogenesis of malignant gliomas
21. Thymic lymphoma induction by the AKT8 murine retrovirus
22. HIF-1 and human disease: One highly involved factor
23. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1
24. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular 02 tension
25. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
26. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
27. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
28. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
29. 2 homeostasis by hypoxia-inducible factor 1 α
30. HIF-1 α is required for solid tumor formation and embryonic vascularization
31. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
32. Loss of PTEN facilitates HIF-1-mediated gene expression
33. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
34. 1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
35. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation
36. Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-α
37. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
38. The von Hippel-Lindau tumor suppressor protein
39. 2-dependent degradation domain via the ubiquitin-proteasome pathway
40. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway
41. Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
42. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
43. Activation of HIF1α ubiquitination by a reconstituted von Hippel- Lindau (VHL) tumor suppressor complex
44. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
45. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein
46. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
47. Mutational spectra of PTEN/MMAC1 gene: A tumor suppressor with lipid phosphatase activity
48. 2 tension
49. Cloning of a factor required for activity of the Ah (dioxin) receptor
50. Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT)
51. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action